Dr. Spaggiari on Surgical Strategies to Improve Liver Remnants in CRC With Liver Metastases

Video

In Partnership With:

Mario Spaggiari, MD, discusses surgical strategies to improve liver remnants in colorectal cancer with liver metastases.

Mario Spaggiari, MD, transplant surgeon, Division of Transplantation, University of Illinois Health, discusses surgical strategies to improve liver remnants in colorectal cancer (CRC) with liver metastases.

The liver remnant, or how much liver is left after surgery, is an important aspect of a successful surgical resection for patients with CRC and liver metastases, Spaggiari says. As such, different surgical approaches can be utilized to increase the size of non-malignant liver in preparation for surgery, including portal vein embolization. With this strategy, the liver can be restaged after 2 to 3 weeks following portal vein embolization and then the patient can be reassessed for surgery.

Additionally, aggressive surgical procedures that can increase the size of the liver in a shorter period can be utilized if the patient requires more immediate surgery, Spaggiari explains. For example, utilizing surgery in combination with interventional radiology allows for a patient to undergo a large surgery with a significantly increased liver remnant within a period of 7 to 15 days, Spaggiari concludes.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD